文献速递针灸推拿中药与中成药合理使用

肾俞穴注射脂肪干细胞联合富血小板纤维蛋白释放物治疗兔急性肾损伤

Effect of injecting adipose stem cells combined with platelet-rich fibrin releasate at Shenshu acupoint (BL23) on acute kidney injury in rabbits.
PubMed 文献 · Front Pharmacol · 2025-03-12

本研究在急性肾损伤新西兰白兔模型肾俞穴(BL23)注射脂肪干细胞(ADSCs)、富血小板纤维蛋白释放物(PRFr)或两者联合,评估肾功能与组织修复。联合组在第2周血清肌酐和尿素氮显著降低,第7周肾修复效果最佳,肾小球完整、肾小管上皮无明显水肿或空泡样改变、周围组织无明显炎症细胞浸润。

要点

  • 肾俞穴注射ADSCs联合PRFr可改善兔急性肾损伤的肾功能。
  • 联合组第2周血清肌酐和尿素氮显著降低。
  • 联合组第7周肾组织修复效果最佳。

核心结论

  • 肾俞穴注射PRFr、ADSCs及其联合可修复受损肾细胞、改善肾功能并降低血清CRE和BUN。
  • 联合组表现出协同效应,可能成为肾损伤的新型治疗策略。

研究设计与样本

  • 研究为兔急性肾损伤模型实验,采用新西兰白兔。
  • 治疗组在肾俞穴(BL23)分别注射ADSCs、PRFr或两者联合。

主要发现

  • PRFr+ADSCs组在移植后第2周血清CRE和BUN水平显著降低。
  • 治疗7周后PRFr+ADSCs组肾修复效果最佳,肾小球完整、肾小管上皮细胞无水肿或空泡样改变、周围组织无明显炎症细胞浸润。

临床怎么用

  • 该结果为动物实验阶段,尚不能直接用于临床决策。
  • 需进一步研究优化治疗方案并阐明机制。

局限性

  • 原文未报告样本量、具体数值、P值等统计细节。
  • 研究为兔模型,外推到人类需谨慎。
  • 需进一步研究优化治疗协议并阐明潜在机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Acute kidney injury (AKI) is a major and unmet medical need, characterized by a sudden onset of kidney dysfunction that often occurs within 7 days. Adipose-derived stem cells (ADSCs) are known for their regenerative, differentiative, and repair abilities, making them a promising therapeutic option for kidney injury. Platelet-rich fibrin releasate (PRFr), derived from platelet-rich fibrin after static incubation, contains numerous growth factors that may promote the differentiation and proliferation of stem cells. Additionally, acupoints such as Shenshu (BL23) have been used in clinical practice and experimental settings, particularly in renal failure treatments. METHODS: This study aimed to evaluate the synergistic effects of ADSCs and PRFr, administered separately or in combination, at the Shenshu acupoint (BL23) in New Zealand white rabbits with acute kidney injury. The treatment groups were injected with ADSCs, PRFr, or a combination of both. Serum creatinine (CRE) and blood urea nitrogen (BUN) levels were measured to assess kidney function. Additionally, histological examination of kidney tissue was performed to observe morphological changes and tissue repair. RESULTS: The PRFr + ADSCs treatment group exhibited a significant reduction in CRE and BUN levels during the second week following transplantation. After 7 weeks of treatment, the PRFr + ADSCs group showed the most favorable kidney repair outcomes, with intact glomeruli, no edema or vacuole-like changes in the renal tubular epithelial cells, and no significant infiltration of inflammatory cells in the surrounding tissues. DISCUSSION: The administration of PRFr, ADSCs, and their combination at the Shenshu acupoint (BL23) demonstrated a potential therapeutic effect in repairing damaged renal cells, improving kidney function, and reducing serum CRE and BUN levels. These findings suggest that injection of PRFr, ADSCs, and their combination at the Shenshu acupoint (BL23) can effectively repair damaged renal cells and improve kidney function in AKI. The observed synergistic effect indicates that this approach holds potential as a novel therapeutic strategy for kidney injury. Further research is needed to optimize treatment protocols and elucidate the underlying mechanisms.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Chuang HN, Pei W, Kuo TF, et al. Effect of injecting adipose stem cells combined with platelet-rich fibrin releasate at Shenshu acupoint (BL23) on acute kidney injury in rabbits. Front Pharmacol. 2025. PMID: 40144656. doi:10.3389/fphar.2025.1409056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。